疾病通路的编号,疾病名称,通路名称(Name),通路编号(Entry),文章引用（Title）,文章DOI,文章链接
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to mGluR5-Ca2+ -apoptotic pathway,N01002,Relationship Between beta-Amyloid and Mitochondrial Dynamics.,10.1007/s10571-016-0434-4,https://doi.org/10.1007/s10571-016-0434-4
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to mGluR5-Ca2+ -apoptotic pathway,N01002,Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease.,10.1007/s10571-016-0434-4,https://doi.org/10.1007/s10571-016-0434-4
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to mGluR5-Ca2+ -apoptotic pathway,N01008,The gain-of-function enhancement of IP3-receptor channel gating by familial Alzheimer's disease-linked presenilin mutants increases the open probability of mitochondrial permeability transition pore.,10.1016/j.ceca.2016.05.002,https://doi.org/10.1016/j.ceca.2016.05.002
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to mGluR5-Ca2+ -apoptotic pathway,N01008,Presenilins: role in calcium homeostasis.,10.1016/j.ceca.2016.05.002,https://doi.org/10.1016/j.ceca.2016.05.002
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to mGluR5-Ca2+ -apoptotic pathway,N01008,ER calcium and Alzheimer's disease: in a state of flux.,10.1016/j.ceca.2016.05.002,https://doi.org/10.1016/j.ceca.2016.05.002
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to mGluR5-Ca2+ -apoptotic pathway,N01008,Presenilin-mediated signal transduction.,10.1016/j.ceca.2016.05.002,https://doi.org/10.1016/j.ceca.2016.05.002
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN to mGluR5-Ca2+ -apoptotic pathway,N01007,PS2 mutation increases neuronal cell vulnerability to neurotoxicants through activation of caspase-3 by enhancing of ryanodine receptor-mediated calcium release.,10.1096/fj.05-4017fje;1,https://doi.org/10.1096/fj.05-4017fje;1
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN to mGluR5-Ca2+ -apoptotic pathway,N01007,Presenilins: role in calcium homeostasis.,10.1096/fj.05-4017fje;1,https://doi.org/10.1096/fj.05-4017fje;1
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN to mGluR5-Ca2+ -apoptotic pathway,N01007,Presenilin-mediated signal transduction.,10.1096/fj.05-4017fje;1,https://doi.org/10.1096/fj.05-4017fje;1
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to mAchR-Ca2+ -apoptotic pathway,N01001,Role of GPCR signaling and calcium dysregulation in Alzheimer's disease.,10.1016/j.mcn.2019.103414,https://doi.org/10.1016/j.mcn.2019.103414
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to mAchR-Ca2+ -apoptotic pathway,N01001,Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease.,10.1016/j.mcn.2019.103414,https://doi.org/10.1016/j.mcn.2019.103414
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to mAchR-Ca2+ -apoptotic pathway,N01001,Mitochondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs.,10.1016/j.mcn.2019.103414,https://doi.org/10.1016/j.mcn.2019.103414
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to VGCC-Ca2+ -apoptotic pathway,N01004,Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease.,10.1089/ars.2018.7506,https://doi.org/10.1089/ars.2018.7506
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to VGCC-Ca2+ -apoptotic pathway,N01006,Killing Me Softly: Connotations to Unfolded Protein Response and Oxidative Stress in Alzheimer's Disease.,10.1155/2016/1805304,https://doi.org/10.1155/2016/1805304
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to VGCC-Ca2+ -apoptotic pathway,N01006,Calcium channel blockers and Alzheimer's disease.,10.1155/2016/1805304,https://doi.org/10.1155/2016/1805304
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to VGCC-Ca2+ -apoptotic pathway,N01006,Mitochondrial permeability transition pore in Alzheimer's disease: cyclophilin D and amyloid beta.,10.1155/2016/1805304,https://doi.org/10.1155/2016/1805304
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to transport of calcium,N01003,Mitochondrial Ca2+ overload underlies Abeta oligomers neurotoxicity providing an unexpected mechanism of neuroprotection by NSAIDs.,10.1371/journal.pone.0002718,https://doi.org/10.1371/journal.pone.0002718
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to transport of calcium,N01003,Dysregulation of Intracellular Calcium Signaling in Alzheimer's Disease.,10.1371/journal.pone.0002718,https://doi.org/10.1371/journal.pone.0002718
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to 26S proteasome-mediated protein degradation,N01060,A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers.,10.1038/s41467-018-03509-0,https://doi.org/10.1038/s41467-018-03509-0
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to 26S proteasome-mediated protein degradation,N01060,Could a Common Mechanism of Protein Degradation Impairment Underlie Many Neurodegenerative Diseases?,10.1038/s41467-018-03509-0,https://doi.org/10.1038/s41467-018-03509-0
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to 26S proteasome-mediated protein degradation,N01060,It Is All about (U)biquitin: Role of Altered Ubiquitin-Proteasome System and UCHL1 in Alzheimer Disease.,10.1038/s41467-018-03509-0,https://doi.org/10.1038/s41467-018-03509-0
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to PERK-ATF4 signaling pathway,N01010,Role of Endoplasmic Reticulum Stress and Unfolded Protein Responses in Health and Diseases.,10.1007/s12291-015-0502-4,https://doi.org/10.1007/s12291-015-0502-4
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to PERK-ATF4 signaling pathway,N01010,Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations.,10.1007/s12291-015-0502-4,https://doi.org/10.1007/s12291-015-0502-4
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to PERK-ATF4 signaling pathway,N01010,Endoplasmic reticulum stress and inflammation in the central nervous system.,10.1007/s12291-015-0502-4,https://doi.org/10.1007/s12291-015-0502-4
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to IRE1a-XBP1 signaling pathway,N01012,Role of Endoplasmic Reticulum Stress and Unfolded Protein Responses in Health and Diseases.,10.1007/s12291-015-0502-4,https://doi.org/10.1007/s12291-015-0502-4
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to IRE1a-XBP1 signaling pathway,N01012,Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations.,10.1007/s12291-015-0502-4,https://doi.org/10.1007/s12291-015-0502-4
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to IRE1a-XBP1 signaling pathway,N01012,The role of endoplasmic reticulum stress in neurodegenerative disease.,10.1007/s12291-015-0502-4,https://doi.org/10.1007/s12291-015-0502-4
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to IRE1a-XBP1 signaling pathway,N01012,Endoplasmic reticulum stress and inflammation in the central nervous system.,10.1007/s12291-015-0502-4,https://doi.org/10.1007/s12291-015-0502-4
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to IRE1a-JNK signaling pathway,N01014,Endoplasmic reticulum dysfunction in Alzheimer's disease.,10.1007/s12035-014-8695-8,https://doi.org/10.1007/s12035-014-8695-8
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to IRE1a-JNK signaling pathway,N01014,Apoptosis signal regulating kinase 1 (ASK1): potential as a therapeutic target for Alzheimer's disease.,10.1007/s12035-014-8695-8,https://doi.org/10.1007/s12035-014-8695-8
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to ATF6-mediated transcription,N01016,Disturbed activation of endoplasmic reticulum stress transducers by familial Alzheimer's disease-linked presenilin-1 mutations.,10.1074/jbc.M104096200,https://doi.org/10.1074/jbc.M104096200
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to ATF6-mediated transcription,N01016,Induction of neuronal death by ER stress in Alzheimer's disease.,10.1074/jbc.M104096200,https://doi.org/10.1074/jbc.M104096200
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to crosstalk between extrinsic and intrinsic apoptotic pathways,N01005,Alzheimer's disease and Abeta toxicity: from top to bottom.,10.1038/35086072,https://doi.org/10.1038/35086072
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to crosstalk between extrinsic and intrinsic apoptotic pathways,N01005,Distinct destructive signal pathways of neuronal death in Alzheimer's disease.,10.1038/35086072,https://doi.org/10.1038/35086072
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to crosstalk between extrinsic and intrinsic apoptotic pathways,N01005,Neuronal apoptosis induced by beta-amyloid is mediated by caspase-8.,10.1038/35086072,https://doi.org/10.1038/35086072
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway,N00996,Alzheimer's disease and Abeta toxicity: from top to bottom.,10.1038/35086072,https://doi.org/10.1038/35086072
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway,N00996,Advanced glycation endproducts and their receptor RAGE in Alzheimer's disease.,10.1038/35086072,https://doi.org/10.1038/35086072
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway,N00996,"MAPK, beta-amyloid and synaptic dysfunction: the role of RAGE.",10.1038/35086072,https://doi.org/10.1038/35086072
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to AGE-RAGE signaling pathway,N00996,Abeta-dependent Inhibition of LTP in different intracortical circuits of the visual cortex: the role of RAGE.,10.1038/35086072,https://doi.org/10.1038/35086072
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex I,N00997,Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses.,10.1074/jbc.R116.766782,https://doi.org/10.1074/jbc.R116.766782
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex I,N00997,Amyloid-beta oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease.,10.1074/jbc.R116.766782,https://doi.org/10.1074/jbc.R116.766782
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex I,N00997,Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.,10.1074/jbc.R116.766782,https://doi.org/10.1074/jbc.R116.766782
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex I,N00997,Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.,10.1074/jbc.R116.766782,https://doi.org/10.1074/jbc.R116.766782
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex I,N00997,Deregulated Cdk5 activity is involved in inducing Alzheimer's disease.,10.1074/jbc.R116.766782,https://doi.org/10.1074/jbc.R116.766782
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,New Insights on the Role of Manganese in Alzheimer's Disease and Parkinson's Disease.,10.3390/ijerph16193546,https://doi.org/10.3390/ijerph16193546
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,"An analysis of the effects of Mn2+ on oxidative phosphorylation in liver, brain, and heart mitochondria using state 3 oxidation rate assays.",10.3390/ijerph16193546,https://doi.org/10.3390/ijerph16193546
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,Manganese ions induce H2O2 generation at the ubiquinone binding site of mitochondrial complex II.,10.3390/ijerph16193546,https://doi.org/10.3390/ijerph16193546
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex IV,N00999,Mitochondrial dysfunction in sporadic and genetic Alzheimer's disease.,10.1016/j.exger.2006.03.012,https://doi.org/10.1016/j.exger.2006.03.012
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex IV,N00999,Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.,10.1016/j.exger.2006.03.012,https://doi.org/10.1016/j.exger.2006.03.012
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex IV,N00999,Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.,10.1016/j.exger.2006.03.012,https://doi.org/10.1016/j.exger.2006.03.012
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to electron transfer in Complex IV,N00999,Proteomic analysis of mitochondrial dysfunction in neurodegenerative diseases.,10.1016/j.exger.2006.03.012,https://doi.org/10.1016/j.exger.2006.03.012
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to anterograde axonal transport,N01017,Alzheimer's presenilin 1 mutations impair kinesin-based axonal transport.,10.1523/JNEUROSCI.23-11-04499.2003,https://doi.org/10.1523/JNEUROSCI.23-11-04499.2003
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to anterograde axonal transport,N01017,Axonal transport defects: a common theme in neurodegenerative diseases.,10.1523/JNEUROSCI.23-11-04499.2003,https://doi.org/10.1523/JNEUROSCI.23-11-04499.2003
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to anterograde axonal transport,N01017,Presenilin influences glycogen synthase kinase-3 beta (GSK-3beta) for kinesin-1 and dynein function during axonal transport.,10.1523/JNEUROSCI.23-11-04499.2003,https://doi.org/10.1523/JNEUROSCI.23-11-04499.2003
hsa05010,Alzheimer disease,Mutation-caused aberrant PSEN1 to anterograde axonal transport,N01017,Axonal transport defects in Alzheimer's disease.,10.1523/JNEUROSCI.23-11-04499.2003,https://doi.org/10.1523/JNEUROSCI.23-11-04499.2003
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to anterograde axonal transport,N01018,Reelin: Neurodevelopmental Architect and Homeostatic Regulator of Excitatory Synapses.,10.1074/jbc.R116.766782,https://doi.org/10.1074/jbc.R116.766782
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to anterograde axonal transport,N01018,Amyloid-beta oligomers synaptotoxicity: The emerging role of EphA4/c-Abl signaling in Alzheimer's disease.,10.1074/jbc.R116.766782,https://doi.org/10.1074/jbc.R116.766782
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to anterograde axonal transport,N01018,Axonal transport defects in Alzheimer's disease.,10.1074/jbc.R116.766782,https://doi.org/10.1074/jbc.R116.766782
hsa05010,Alzheimer disease,Mutation-caused aberrant Abeta to anterograde axonal transport,N01018,"Abeta oligomers cause localized Ca(2+) elevation, missorting of endogenous Tau into dendrites, Tau phosphorylation, and destruction of microtubules and spines.",10.1074/jbc.R116.766782,https://doi.org/10.1074/jbc.R116.766782
hsa05010,Alzheimer disease,Zn to anterograde axonal transport,N01403,Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.,10.3389/fnmol.2017.00339,https://doi.org/10.3389/fnmol.2017.00339
hsa05010,Alzheimer disease,Zn to anterograde axonal transport,N01403,Current understanding of metal ions in the pathogenesis of Alzheimer's disease.,10.3389/fnmol.2017.00339,https://doi.org/10.3389/fnmol.2017.00339
hsa05010,Alzheimer disease,Zn to anterograde axonal transport,N01403,Axonal transport defects in Alzheimer's disease.,10.3389/fnmol.2017.00339,https://doi.org/10.3389/fnmol.2017.00339
hsa05010,Alzheimer disease,Zn to anterograde axonal transport,N01403,Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer's disease.,10.3389/fnmol.2017.00339,https://doi.org/10.3389/fnmol.2017.00339
hsa05010,Alzheimer disease,Iron to anterograde axonal transport,N01414,Biometal Dyshomeostasis and Toxic Metal Accumulations in the Development of Alzheimer's Disease.,10.3389/fnmol.2017.00339,https://doi.org/10.3389/fnmol.2017.00339
hsa05010,Alzheimer disease,Iron to anterograde axonal transport,N01414,Current understanding of metal ions in the pathogenesis of Alzheimer's disease.,10.3389/fnmol.2017.00339,https://doi.org/10.3389/fnmol.2017.00339
hsa05010,Alzheimer disease,Iron to anterograde axonal transport,N01414,Axonal transport defects in Alzheimer's disease.,10.3389/fnmol.2017.00339,https://doi.org/10.3389/fnmol.2017.00339
hsa05010,Alzheimer disease,Iron to anterograde axonal transport,N01414,Deferoxamine inhibits iron induced hippocampal tau phosphorylation in the Alzheimer transgenic mouse brain.,10.3389/fnmol.2017.00339,https://doi.org/10.3389/fnmol.2017.00339
hsa05010,Alzheimer disease,Iron to anterograde axonal transport,N01414,Tau hyperphosphorylation induces apoptotic escape and triggers neurodegeneration in Alzheimer's disease.,10.3389/fnmol.2017.00339,https://doi.org/10.3389/fnmol.2017.00339
hsa05010,Alzheimer disease,Mercury to NEP-mediated Abeta degradation,N01416,Mercury Reduces the Enzymatic Activity of Neprilysin in Differentiated SH-SY5Y Cells.,10.1093/toxsci/kfv037,https://doi.org/10.1093/toxsci/kfv037
hsa05010,Alzheimer disease,Mercury to NEP-mediated Abeta degradation,N01416,Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases.,10.1093/toxsci/kfv037,https://doi.org/10.1093/toxsci/kfv037
hsa05010,Alzheimer disease,Mercury to NEP-mediated Abeta degradation,N01416,Emerging risk of environmental factors: insight mechanisms of Alzheimer's diseases.,10.1093/toxsci/kfv037,https://doi.org/10.1093/toxsci/kfv037
hsa05012,Parkinson disease,Mutation-inactivated PRKN to mGluR1 signaling pathway,N01032,Calcium signaling in Parkinson's disease.,10.1007/s00441-014-1866-0,https://doi.org/10.1007/s00441-014-1866-0
hsa05012,Parkinson disease,Mutation-inactivated PRKN to mGluR1 signaling pathway,N01032,Parkin deficiency disrupts calcium homeostasis by modulating phospholipase C signalling.,10.1007/s00441-014-1866-0,https://doi.org/10.1007/s00441-014-1866-0
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to VGCC-Ca2+ -apoptotic pathway,N01031,Calcium signaling and neurodegenerative diseases.,10.1016/j.molmed.2009.01.001,https://doi.org/10.1016/j.molmed.2009.01.001
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to VGCC-Ca2+ -apoptotic pathway,N01031,The role of Ca(2+) signaling in Parkinson's disease.,10.1016/j.molmed.2009.01.001,https://doi.org/10.1016/j.molmed.2009.01.001
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to VGCC-Ca2+ -apoptotic pathway,N01031,Calcium signaling in Parkinson's disease.,10.1016/j.molmed.2009.01.001,https://doi.org/10.1016/j.molmed.2009.01.001
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01020,Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease.,10.1126/science.1060627,https://doi.org/10.1126/science.1060627
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01020,Part I: parkin-associated proteins and Parkinson's disease.,10.1126/science.1060627,https://doi.org/10.1126/science.1060627
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01022,Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.,10.1074/jbc.C000447200,https://doi.org/10.1074/jbc.C000447200
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01022,Part I: parkin-associated proteins and Parkinson's disease.,10.1074/jbc.C000447200,https://doi.org/10.1074/jbc.C000447200
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01022,Endoplasmic reticulum stress and Parkinson's disease: the role of HRD1 in averting apoptosis in neurodegenerative disease.,10.1074/jbc.C000447200,https://doi.org/10.1074/jbc.C000447200
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01024,"Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.",10.1073/pnas.240347797,https://doi.org/10.1073/pnas.240347797
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01024,Part I: parkin-associated proteins and Parkinson's disease.,10.1073/pnas.240347797,https://doi.org/10.1073/pnas.240347797
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01026,"Parkin ubiquitinates the alpha-synuclein-interacting protein, synphilin-1: implications for Lewy-body formation in Parkinson disease.",10.1038/nm1001-1144,https://doi.org/10.1038/nm1001-1144
hsa05012,Parkinson disease,Mutation-inactivated PRKN to Parkin-mediated ubiquitination,N01026,Part I: parkin-associated proteins and Parkinson's disease.,10.1038/nm1001-1144,https://doi.org/10.1038/nm1001-1144
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to 26S proteasome-mediated protein degradation,N01030,Expanding insights of mitochondrial dysfunction in Parkinson's disease.,10.1038/nrn1868,https://doi.org/10.1038/nrn1868
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to 26S proteasome-mediated protein degradation,N01030,The Proteasome Inhibition Model of Parkinson's Disease.,10.1038/nrn1868,https://doi.org/10.1038/nrn1868
hsa05012,Parkinson disease,Mutation-inactivated UCHL1 to UCHL1-mediated hydrolysis,N01028,Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants.,10.1016/s0006-291x(03)00555-2,https://doi.org/10.1016/s0006-291x(03)00555-2
hsa05012,Parkinson disease,Mutation-inactivated UCHL1 to UCHL1-mediated hydrolysis,N01028,Dysregulation of Ubiquitin-Proteasome System in Neurodegenerative Diseases.,10.1016/s0006-291x(03)00555-2,https://doi.org/10.1016/s0006-291x(03)00555-2
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to PERK-ATF4 signaling pathway,N01035,An ERcentric view of Parkinson's disease.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to PERK-ATF4 signaling pathway,N01035,ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to PERK-ATF4 signaling pathway,N01035,Modulation of endoplasmic reticulum stress in Parkinson's disease.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to PERK-ATF4 signaling pathway,N01035,Oxyresveratrol exerts ATF4- and Grp78-mediated neuroprotection against endoplasmic reticulum stress in experimental Parkinson's disease.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to IRE1a-XBP1 signaling pathway,N01034,An ERcentric view of Parkinson's disease.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to IRE1a-XBP1 signaling pathway,N01034,ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to IRE1a-XBP1 signaling pathway,N01034,Modulation of endoplasmic reticulum stress in Parkinson's disease.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to IRE1a-XBP1 signaling pathway,N01034,Oxyresveratrol exerts ATF4- and Grp78-mediated neuroprotection against endoplasmic reticulum stress in experimental Parkinson's disease.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to ATF6-mediated transcription,N01033,An ERcentric view of Parkinson's disease.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to ATF6-mediated transcription,N01033,ER stress and Parkinson's disease: Pathological inputs that converge into the secretory pathway.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to ATF6-mediated transcription,N01033,Modulation of endoplasmic reticulum stress in Parkinson's disease.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to ATF6-mediated transcription,N01033,Oxyresveratrol exerts ATF4- and Grp78-mediated neuroprotection against endoplasmic reticulum stress in experimental Parkinson's disease.,10.1016/j.molmed.2012.12.005,https://doi.org/10.1016/j.molmed.2012.12.005
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to PINK1-Parkin-mediated MFN2 degradation,N01053,Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts.,10.1371/journal.pone.0016746,https://doi.org/10.1371/journal.pone.0016746
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to PINK1-Parkin-mediated MFN2 degradation,N01053,"Parkinson's disease and cancer: two wars, one front.",10.1371/journal.pone.0016746,https://doi.org/10.1371/journal.pone.0016746
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to PINK1-Parkin-mediated MFN2 degradation,N01053,"PINK1, Parkin, and Mitochondrial Quality Control: What can we Learn about Parkinson's Disease Pathobiology?",10.1371/journal.pone.0016746,https://doi.org/10.1371/journal.pone.0016746
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to PINK1-Parkin-mediated MFN2 degradation,N01053,Heterozygous PINK1 p.G411S increases risk of Parkinson's disease via a dominant-negative mechanism.,10.1371/journal.pone.0016746,https://doi.org/10.1371/journal.pone.0016746
hsa05012,Parkinson disease,Mutation-inactivated PRKN to PINK1-Parkin-mediated MFN2 degradation,N01054,Mutations in PINK1 and Parkin impair ubiquitination of Mitofusins in human fibroblasts.,10.1371/journal.pone.0016746,https://doi.org/10.1371/journal.pone.0016746
hsa05012,Parkinson disease,Mutation-inactivated PRKN to PINK1-Parkin-mediated MFN2 degradation,N01054,"Parkinson's disease and cancer: two wars, one front.",10.1371/journal.pone.0016746,https://doi.org/10.1371/journal.pone.0016746
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to intrinsic apoptotic pathway,N01051,Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.,10.1007/s10863-019-09798-4,https://doi.org/10.1007/s10863-019-09798-4
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to intrinsic apoptotic pathway,N01051,Structural basis for the interaction between DJ-1 and Bcl-XL.,10.1007/s10863-019-09798-4,https://doi.org/10.1007/s10863-019-09798-4
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01050,PINK1 mutants associated with recessive Parkinson's disease are defective in inhibiting mitochondrial release of cytochrome c.,10.1016/j.nbd.2007.07.010,https://doi.org/10.1016/j.nbd.2007.07.010
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01050,The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?,10.1016/j.nbd.2007.07.010,https://doi.org/10.1016/j.nbd.2007.07.010
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01050,Mitochondrial dysfunction in Parkinson's disease.,10.1016/j.nbd.2007.07.010,https://doi.org/10.1016/j.nbd.2007.07.010
hsa05012,Parkinson disease,Mutation-inactivated PRKN to intrinsic apoptotic pathway,N01049,Inhibition of apoptotic Bax translocation to the mitochondria is a central function of parkin.,10.1038/cddis.2014.278,https://doi.org/10.1038/cddis.2014.278
hsa05012,Parkinson disease,Mutation-inactivated PRKN to intrinsic apoptotic pathway,N01049,The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?,10.1038/cddis.2014.278,https://doi.org/10.1038/cddis.2014.278
hsa05012,Parkinson disease,Mutation-inactivated PRKN to intrinsic apoptotic pathway,N01049,Mitochondrial dysfunction in Parkinson's disease.,10.1038/cddis.2014.278,https://doi.org/10.1038/cddis.2014.278
hsa05012,Parkinson disease,Mutation-inactivated PRKN to intrinsic apoptotic pathway,N01049,Parkin inhibits BAK and BAX apoptotic function by distinct mechanisms during mitophagy.,10.1038/cddis.2014.278,https://doi.org/10.1038/cddis.2014.278
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01048,"Mitochondrial dynamics, cell death and the pathogenesis of Parkinson's disease.",10.1007/s10495-010-0465-0,https://doi.org/10.1007/s10495-010-0465-0
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01048,PINK1 protects against oxidative stress by phosphorylating mitochondrial chaperone TRAP1.,10.1007/s10495-010-0465-0,https://doi.org/10.1007/s10495-010-0465-0
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01048,Mitochondrial quality control and neurological disease: an emerging connection.,10.1007/s10495-010-0465-0,https://doi.org/10.1007/s10495-010-0465-0
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01048,The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?,10.1007/s10495-010-0465-0,https://doi.org/10.1007/s10495-010-0465-0
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to intrinsic apoptotic pathway,N01048,Mitochondrial dysfunction in Parkinson's disease.,10.1007/s10495-010-0465-0,https://doi.org/10.1007/s10495-010-0465-0
hsa05012,Parkinson disease,Mutation-activated LRRK2 to intrinsic apoptotic pathway,N01047,The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Mutation-activated LRRK2 to intrinsic apoptotic pathway,N01047,Mitochondrial dysfunction in Parkinson's disease.,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Mutation-activated LRRK2 to intrinsic apoptotic pathway,N01047,Apoptotic mechanisms in mutant LRRK2-mediated cell death.,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to FAS-JNK signaling patwhay,N01057,Regulation of Signal Transduction by DJ-1.,10.1007/978-981-10-6583-5_8,https://doi.org/10.1007/978-981-10-6583-5_8
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to FAS-JNK signaling patwhay,N01057,Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death.,10.1007/978-981-10-6583-5_8,https://doi.org/10.1007/978-981-10-6583-5_8
hsa05012,Parkinson disease,Paraquat to FAS-JNK signaling pathway,N01417,Activation of apoptosis signal-regulating kinase 1 is a key factor in paraquat-induced cell death: modulation by the Nrf2/Trx axis.,10.1016/j.freeradbiomed.2010.02.024,https://doi.org/10.1016/j.freeradbiomed.2010.02.024
hsa05012,Parkinson disease,Paraquat to FAS-JNK signaling pathway,N01417,Environmental pollutants as risk factors for neurodegenerative disorders: Alzheimer and Parkinson diseases.,10.1016/j.freeradbiomed.2010.02.024,https://doi.org/10.1016/j.freeradbiomed.2010.02.024
hsa05012,Parkinson disease,Paraquat to FAS-JNK signaling pathway,N01417,Paraquat exposure as an etiological factor of Parkinson's disease.,10.1016/j.freeradbiomed.2010.02.024,https://doi.org/10.1016/j.freeradbiomed.2010.02.024
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to L-DOPA generation,N01037,A role for alpha-synuclein in the regulation of dopamine biosynthesis.,10.1523/JNEUROSCI.22-08-03090.2002,https://doi.org/10.1523/JNEUROSCI.22-08-03090.2002
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to L-DOPA generation,N01037,Could a loss of alpha-synuclein function put dopaminergic neurons at risk?,10.1523/JNEUROSCI.22-08-03090.2002,https://doi.org/10.1523/JNEUROSCI.22-08-03090.2002
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to L-DOPA generation,N01037,The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson's disease.,10.1523/JNEUROSCI.22-08-03090.2002,https://doi.org/10.1523/JNEUROSCI.22-08-03090.2002
hsa05012,Parkinson disease,Mutation-inactivated PRKN to DOPAL generation,N01039,Parkin gene inactivation alters behaviour and dopamine neurotransmission in the mouse.,10.1093/hmg/ddg239,https://doi.org/10.1093/hmg/ddg239
hsa05012,Parkinson disease,Mutation-inactivated PRKN to DOPAL generation,N01039,"Differential effects of l-DOPA on monoamine metabolism, cell survival and glutathione production in midbrain neuronal-enriched cultures from parkin knockout and wild-type mice.",10.1093/hmg/ddg239,https://doi.org/10.1093/hmg/ddg239
hsa05012,Parkinson disease,Mutation-inactivated PRKN to DOPAL generation,N01039,Modulation of monoamine oxidase (MAO) expression in neuropsychiatric disorders: genetic and environmental factors involved in type A MAO expression.,10.1093/hmg/ddg239,https://doi.org/10.1093/hmg/ddg239
hsa05012,Parkinson disease,Mutation-inactivated PRKN to DOPAL generation,N01039,The interplay between parkin and alpha-synuclein; possible implications for the pathogenesis of Parkinson's disease.,10.1093/hmg/ddg239,https://doi.org/10.1093/hmg/ddg239
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to electron transfer in Complex I,N01042,The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to electron transfer in Complex I,N01042,Mitochondrial dysfunction in Parkinson's disease.,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to electron transfer in Complex I,N01042,"Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.",10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to electron transfer in Complex I,N01043,The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to electron transfer in Complex I,N01043,Mitochondrial dysfunction in Parkinson's disease.,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to electron transfer in Complex I,N01043,"Mitochondria, calcium, and endoplasmic reticulum stress in Parkinson's disease.",10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to electron transfer in Complex I,N01043,The antioxidant Trolox helps recovery from the familial Parkinson's disease-specific mitochondrial deficits caused by PINK1- and DJ-1-deficiency in dopaminergic neuronal cells.,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Mutation-inactivated PINK1 to electron transfer in Complex I,N01043,"Mitochondrial dysfunction, peroxidation damage and changes in glutathione metabolism in PARK6.",10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,MPP+ to electron transfer in Complex I,N01044,The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,MPP+ to electron transfer in Complex I,N01044,Apoptosis inducing factor mediates caspase-independent 1-methyl-4-phenylpyridinium toxicity in dopaminergic cells.,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,MPP+ to electron transfer in Complex I,N01044,Mitochondrial dysfunction in Parkinson's disease.,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Rotenone to electron transfer in Complex I,N01045,The Parkinson Disease Mitochondrial Hypothesis: Where Are We at?,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Rotenone to electron transfer in Complex I,N01045,Chronic systemic pesticide exposure reproduces features of Parkinson's disease.,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Rotenone to electron transfer in Complex I,N01045,Mitochondrial dysfunction in Parkinson's disease.,10.1177/1073858415574600,https://doi.org/10.1177/1073858415574600
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,New Insights on the Role of Manganese in Alzheimer's Disease and Parkinson's Disease.,10.3390/ijerph16193546,https://doi.org/10.3390/ijerph16193546
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,"An analysis of the effects of Mn2+ on oxidative phosphorylation in liver, brain, and heart mitochondria using state 3 oxidation rate assays.",10.3390/ijerph16193546,https://doi.org/10.3390/ijerph16193546
hsa05012,Parkinson disease,Manganese to electron transfer in Complex II,N01402,Manganese ions induce H2O2 generation at the ubiquinone binding site of mitochondrial complex II.,10.3390/ijerph16193546,https://doi.org/10.3390/ijerph16193546
hsa05012,Parkinson disease,Maneb to electron transfer in Complex III,N01046,Melatoninergic System in Parkinson's Disease: From Neuroprotection to the Management of Motor and Nonmotor Symptoms.,10.1155/2016/3472032,https://doi.org/10.1155/2016/3472032
hsa05012,Parkinson disease,Maneb to electron transfer in Complex III,N01046,Manganese ethylene-bis-dithiocarbamate and selective dopaminergic neurodegeneration in rat: a link through mitochondrial dysfunction.,10.1155/2016/3472032,https://doi.org/10.1155/2016/3472032
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to anterograde axonal transport,N01055,"Alpha-Synuclein Toxicity on Protein Quality Control, Mitochondria and Endoplasmic Reticulum.",10.1007/s11064-018-2673-x,https://doi.org/10.1007/s11064-018-2673-x
hsa05012,Parkinson disease,Mutation-caused aberrant SNCA to anterograde axonal transport,N01055,Intracellular and Intercellular Mitochondrial Dynamics in Parkinson's Disease.,10.1007/s11064-018-2673-x,https://doi.org/10.1007/s11064-018-2673-x
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to to p53-mediated transcription,N01058,Regulation of Signal Transduction by DJ-1.,10.1007/978-981-10-6583-5_8,https://doi.org/10.1007/978-981-10-6583-5_8
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to to p53-mediated transcription,N01058,Oxidized DJ-1 inhibits p53 by sequestering p53 from promoters in a DNA-binding affinity-dependent manner.,10.1007/978-981-10-6583-5_8,https://doi.org/10.1007/978-981-10-6583-5_8
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to KEAP1-NRF2 signaling pathway,N01059,Role of DJ-1 in the mechanism of pathogenesis of Parkinson's disease.,10.1007/s10863-019-09798-4,https://doi.org/10.1007/s10863-019-09798-4
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to KEAP1-NRF2 signaling pathway,N01059,Recent findings on the physiological function of DJ-1: Beyond Parkinson's disease.,10.1007/s10863-019-09798-4,https://doi.org/10.1007/s10863-019-09798-4
hsa05012,Parkinson disease,Mutation-inactivated DJ1 to KEAP1-NRF2 signaling pathway,N01059,Basic Concepts on the Role of Nuclear Factor Erythroid-Derived 2-Like 2 (Nrf2) in Age-Related Diseases.,10.1007/s10863-019-09798-4,https://doi.org/10.1007/s10863-019-09798-4
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated SIGMAR1 to Ca2+ -apoptotic pathway,N01151,Loss of function of the ALS protein SigR1 leads to ER pathology associated with defective autophagy and lipid raft disturbances.,10.1038/cddis.2014.243,https://doi.org/10.1038/cddis.2014.243
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated SIGMAR1 to Ca2+ -apoptotic pathway,N01151,"Altered localization, abnormal modification and loss of function of Sigma receptor-1 in amyotrophic lateral sclerosis.",10.1038/cddis.2014.243,https://doi.org/10.1038/cddis.2014.243
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated SIGMAR1 to Ca2+ -apoptotic pathway,N01151,Sigma-1 receptor and amyotrophic lateral sclerosis.,10.1038/cddis.2014.243,https://doi.org/10.1038/cddis.2014.243
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to 26S proteasome-mediated protein degradation,N01144,ALS-linked mutant SOD1 induces ER stress- and ASK1-dependent motor neuron death by targeting Derlin-1.,10.1101/gad.1640108,https://doi.org/10.1101/gad.1640108
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to 26S proteasome-mediated protein degradation,N01144,Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?,10.1101/gad.1640108,https://doi.org/10.1101/gad.1640108
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VCP to 26S proteasome-mediated protein degradation,N01145,Amyotrophic Lateral Sclerosis Pathogenesis Converges on Defects in Protein Homeostasis Associated with TDP-43 Mislocalization and Proteasome-Mediated Degradation Overload.,10.1016/bs.ctdb.2016.07.004,https://doi.org/10.1016/bs.ctdb.2016.07.004
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VCP to 26S proteasome-mediated protein degradation,N01145,Biological and Pathological Implications of an Alternative ATP-Powered Proteasomal Assembly With Cdc48 and the 20S Peptidase.,10.1016/bs.ctdb.2016.07.004,https://doi.org/10.1016/bs.ctdb.2016.07.004
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VCP to 26S proteasome-mediated protein degradation,N01145,An ALS disease mutation in Cdc48/p97 impairs 20S proteasome binding and proteolytic communication.,10.1016/bs.ctdb.2016.07.004,https://doi.org/10.1016/bs.ctdb.2016.07.004
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated UBQLN2 to 26S proteasome-mediated protein degradation,N01146,Amyotrophic Lateral Sclerosis Pathogenesis Converges on Defects in Protein Homeostasis Associated with TDP-43 Mislocalization and Proteasome-Mediated Degradation Overload.,10.1016/bs.ctdb.2016.07.004,https://doi.org/10.1016/bs.ctdb.2016.07.004
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated UBQLN2 to 26S proteasome-mediated protein degradation,N01146,Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.,10.1016/bs.ctdb.2016.07.004,https://doi.org/10.1016/bs.ctdb.2016.07.004
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated UBQLN2 to 26S proteasome-mediated protein degradation,N01146,Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?,10.1016/bs.ctdb.2016.07.004,https://doi.org/10.1016/bs.ctdb.2016.07.004
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to PERK-ATF4 signaling pathway,N01149,ER stress and UPR in familial amyotrophic lateral sclerosis.,10.2174/156652406775574550,https://doi.org/10.2174/156652406775574550
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to PERK-ATF4 signaling pathway,N01149,Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis.,10.2174/156652406775574550,https://doi.org/10.2174/156652406775574550
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to PERK-ATF4 signaling pathway,N01149,Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand.,10.2174/156652406775574550,https://doi.org/10.2174/156652406775574550
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to IRE1a-XBP1 signaling pathway,N01148,ER stress and UPR in familial amyotrophic lateral sclerosis.,10.2174/156652406775574550,https://doi.org/10.2174/156652406775574550
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to IRE1a-XBP1 signaling pathway,N01148,Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis.,10.2174/156652406775574550,https://doi.org/10.2174/156652406775574550
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to IRE1a-XBP1 signaling pathway,N01148,Autophagy Dysregulation in ALS: When Protein Aggregates Get Out of Hand.,10.2174/156652406775574550,https://doi.org/10.2174/156652406775574550
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VAPB to ATF6-mediated transcription,N01150,VAPB interacts with and modulates the activity of ATF6.,10.1093/hmg/ddn040,https://doi.org/10.1093/hmg/ddn040
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VAPB to ATF6-mediated transcription,N01150,Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8).,10.1093/hmg/ddn040,https://doi.org/10.1093/hmg/ddn040
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VAPB to ATF6-mediated transcription,N01150,Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders.,10.1093/hmg/ddn040,https://doi.org/10.1093/hmg/ddn040
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated VAPB to ATF6-mediated transcription,N01150,Protein Homeostasis in Amyotrophic Lateral Sclerosis: Therapeutic Opportunities?,10.1093/hmg/ddn040,https://doi.org/10.1093/hmg/ddn040
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to ATF6-mediated transcription,N01147,Spinal cord endoplasmic reticulum stress associated with a microsomal accumulation of mutant superoxide dismutase-1 in an ALS model.,10.1073/pnas.0509227103,https://doi.org/10.1073/pnas.0509227103
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to ATF6-mediated transcription,N01147,Stress signaling from the endoplasmic reticulum: A central player in the pathogenesis of amyotrophic lateral sclerosis.,10.1073/pnas.0509227103,https://doi.org/10.1073/pnas.0509227103
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to ATF6-mediated transcription,N01147,ER stress and UPR in familial amyotrophic lateral sclerosis.,10.1073/pnas.0509227103,https://doi.org/10.1073/pnas.0509227103
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to ATF6-mediated transcription,N01147,Unfolded proteins and endoplasmic reticulum stress in neurodegenerative disorders.,10.1073/pnas.0509227103,https://doi.org/10.1073/pnas.0509227103
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated C9orf72 to C9orf72-mediated autophagy initiation,N01143,C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy.,10.1080/21541248.2016.1240495,https://doi.org/10.1080/21541248.2016.1240495
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated C9orf72 to C9orf72-mediated autophagy initiation,N01143,Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?,10.1080/21541248.2016.1240495,https://doi.org/10.1080/21541248.2016.1240495
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated C9orf72 to C9orf72-mediated autophagy initiation,N01143,Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS.,10.1080/21541248.2016.1240495,https://doi.org/10.1080/21541248.2016.1240495
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated C9orf72 to C9orf72-mediated autophagy initiation,N01143,Reduced C9ORF72 function exacerbates gain of toxicity from ALS/FTD-causing repeat expansion in C9orf72.,10.1080/21541248.2016.1240495,https://doi.org/10.1080/21541248.2016.1240495
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated OPTN to PINK-Parkin-mediated autophagosome formation,N01138,Autophagy Receptors and Neurodegenerative Diseases.,10.1016/j.tcb.2017.01.001,https://doi.org/10.1016/j.tcb.2017.01.001
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated OPTN to PINK-Parkin-mediated autophagosome formation,N01138,Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities.,10.1016/j.tcb.2017.01.001,https://doi.org/10.1016/j.tcb.2017.01.001
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated OPTN to PINK-Parkin-mediated autophagosome formation,N01138,Dynamic recruitment and activation of ALS-associated TBK1 with its target optineurin are required for efficient mitophagy.,10.1016/j.tcb.2017.01.001,https://doi.org/10.1016/j.tcb.2017.01.001
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated OPTN to PINK-Parkin-mediated autophagosome formation,N01138,Optineurin in amyotrophic lateral sclerosis: Multifunctional adaptor protein at the crossroads of different neuroprotective mechanisms.,10.1016/j.tcb.2017.01.001,https://doi.org/10.1016/j.tcb.2017.01.001
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated p62 to PINK-Parkin-mediated autophagosome formation,N01139,Autophagy as a common pathway in amyotrophic lateral sclerosis.,10.1016/j.neulet.2018.04.006,https://doi.org/10.1016/j.neulet.2018.04.006
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated p62 to PINK-Parkin-mediated autophagosome formation,N01139,Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities.,10.1016/j.neulet.2018.04.006,https://doi.org/10.1016/j.neulet.2018.04.006
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated TBK1 to TBK1-mediated autophagosome formation,N01141,TBK1: a new player in ALS linking autophagy and neuroinflammation.,10.1186/s13041-017-0287-x,https://doi.org/10.1186/s13041-017-0287-x
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated TBK1 to TBK1-mediated autophagosome formation,N01141,Autophagy as a common pathway in amyotrophic lateral sclerosis.,10.1186/s13041-017-0287-x,https://doi.org/10.1186/s13041-017-0287-x
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated TBK1 to TBK1-mediated autophagosome formation,N01141,Autophagy Receptors and Neurodegenerative Diseases.,10.1186/s13041-017-0287-x,https://doi.org/10.1186/s13041-017-0287-x
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated TBK1 to TBK1-mediated autophagosome formation,N01141,Exome sequencing in amyotrophic lateral sclerosis identifies risk genes and pathways.,10.1186/s13041-017-0287-x,https://doi.org/10.1186/s13041-017-0287-x
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated TBK1 to TBK1-mediated autophagosome formation,N01141,Haploinsufficiency of TBK1 causes familial ALS and fronto-temporal dementia.,10.1186/s13041-017-0287-x,https://doi.org/10.1186/s13041-017-0287-x
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to intrinsic apoptotic pathway,N01135,Amyotrophic lateral sclerosis-associated SOD1 mutant proteins bind and aggregate with Bcl-2 in spinal cord mitochondria.,10.1016/j.neuron.2004.06.021,https://doi.org/10.1016/j.neuron.2004.06.021
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to intrinsic apoptotic pathway,N01135,"Caspase-1 and -3 are sequentially activated in motor neuron death in Cu,Zn superoxide dismutase-mediated familial amyotrophic lateral sclerosis.",10.1016/j.neuron.2004.06.021,https://doi.org/10.1016/j.neuron.2004.06.021
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to intrinsic apoptotic pathway,N01135,The role of mitochondria in amyotrophic lateral sclerosis.,10.1016/j.neuron.2004.06.021,https://doi.org/10.1016/j.neuron.2004.06.021
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to intrinsic apoptotic pathway,N01135,Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.,10.1016/j.neuron.2004.06.021,https://doi.org/10.1016/j.neuron.2004.06.021
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated ERBB4 to NRG-ERBB4-PI3K signaling pathway,N01164,ERBB4 mutations that disrupt the neuregulin-ErbB4 pathway cause amyotrophic lateral sclerosis type 19.,10.1016/j.ajhg.2013.09.008,https://doi.org/10.1016/j.ajhg.2013.09.008
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated ERBB4 to NRG-ERBB4-PI3K signaling pathway,N01164,"Altered immunoreactivity of ErbB4, a causative gene product for ALS19, in the spinal cord of patients with sporadic ALS.",10.1016/j.ajhg.2013.09.008,https://doi.org/10.1016/j.ajhg.2013.09.008
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated ERBB4 to NRG-ERBB4-PI3K signaling pathway,N01164,Neuregulin 1 Reduces Motoneuron Cell Death and Promotes Neurite Growth in an in Vitro Model of Motoneuron Degeneration.,10.1016/j.ajhg.2013.09.008,https://doi.org/10.1016/j.ajhg.2013.09.008
hsa05014,Amyotrophic lateral sclerosis,Mutation-inactivated ERBB4 to NRG-ERBB4-PI3K signaling pathway,N01164,Genetics of amyotrophic lateral sclerosis: A review.,10.1016/j.ajhg.2013.09.008,https://doi.org/10.1016/j.ajhg.2013.09.008
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TDP43 to electron transfer in Complex I,N01136,Altered Mitochondrial Dynamics in Motor Neuron Disease: An Emerging Perspective.,10.3390/cells9041065,https://doi.org/10.3390/cells9041065
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TDP43 to electron transfer in Complex I,N01136,The inhibition of TDP-43 mitochondrial localization blocks its neuronal toxicity.,10.3390/cells9041065,https://doi.org/10.3390/cells9041065
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to retrograde axonal transport,N01160,Interaction between familial amyotrophic lateral sclerosis (ALS)-linked SOD1 mutants and the dynein complex.,10.1074/jbc.M609743200,https://doi.org/10.1074/jbc.M609743200
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to retrograde axonal transport,N01160,The role of mitochondria in amyotrophic lateral sclerosis.,10.1074/jbc.M609743200,https://doi.org/10.1074/jbc.M609743200
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant SOD1 to retrograde axonal transport,N01160,Mitochondria: the next (neurode)generation.,10.1074/jbc.M609743200,https://doi.org/10.1074/jbc.M609743200
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant DCTN1 to retrograde axonal transport,N01158,Amyotrophic Lateral Sclerosis.,10.1056/NEJMra1603471,https://doi.org/10.1056/NEJMra1603471
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant DCTN1 to retrograde axonal transport,N01158,Mutant dynactin in motor neuron disease.,10.1056/NEJMra1603471,https://doi.org/10.1056/NEJMra1603471
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TUBA4A to retrograde axonal transport,N01159,Amyotrophic Lateral Sclerosis.,10.1056/NEJMra1603471,https://doi.org/10.1056/NEJMra1603471
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TUBA4A to retrograde axonal transport,N01159,TUBA4A gene analysis in sporadic amyotrophic lateral sclerosis: identification of novel mutations.,10.1056/NEJMra1603471,https://doi.org/10.1056/NEJMra1603471
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant PFN1 to actin polymerization,N01162,Mutations in the profilin 1 gene cause familial amyotrophic lateral sclerosis.,10.1038/nature11280,https://doi.org/10.1038/nature11280
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant PFN1 to actin polymerization,N01162,Amyotrophic Lateral Sclerosis.,10.1038/nature11280,https://doi.org/10.1038/nature11280
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant PFN1 to actin polymerization,N01162,Mutant PFN1 causes ALS phenotypes and progressive motor neuron degeneration in mice by a gain of toxicity.,10.1038/nature11280,https://doi.org/10.1038/nature11280
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TDP43 to TDP-43-regulated splicing,N01155,Alteration of POLDIP3 splicing associated with loss of function of TDP-43 in tissues affected with ALS.,10.1371/journal.pone.0043120,https://doi.org/10.1371/journal.pone.0043120
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TDP43 to TDP-43-regulated splicing,N01155,TDP-43 repression of nonconserved cryptic exons is compromised in ALS-FTD.,10.1371/journal.pone.0043120,https://doi.org/10.1371/journal.pone.0043120
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TDP43 to TDP-43-regulated splicing,N01155,Autophagy and Its Impact on Neurodegenerative Diseases: New Roles for TDP-43 and C9orf72.,10.1371/journal.pone.0043120,https://doi.org/10.1371/journal.pone.0043120
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant TDP43 to TDP-43-regulated splicing,N01155,RNA metabolism in neurodegenerative disease.,10.1371/journal.pone.0043120,https://doi.org/10.1371/journal.pone.0043120
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant FUS to FUS-regulated splicing,N01157,Mechanisms of FUS mutations in familial amyotrophic lateral sclerosis.,10.1016/j.brainres.2016.03.036,https://doi.org/10.1016/j.brainres.2016.03.036
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant FUS to FUS-regulated splicing,N01157,RNA-Binding Proteins in Amyotrophic Lateral Sclerosis.,10.1016/j.brainres.2016.03.036,https://doi.org/10.1016/j.brainres.2016.03.036
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant FUS to FUS-regulated splicing,N01157,RNA Dysregulation in Amyotrophic Lateral Sclerosis.,10.1016/j.brainres.2016.03.036,https://doi.org/10.1016/j.brainres.2016.03.036
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant GLE1 to nuclear export of mRNA,N01153,Lost in Transportation: Nucleocytoplasmic Transport Defects in ALS and Other Neurodegenerative Diseases.,10.1016/j.neuron.2017.07.029,https://doi.org/10.1016/j.neuron.2017.07.029
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant GLE1 to nuclear export of mRNA,N01153,"Deleterious mutations in the essential mRNA metabolism factor, hGle1, in amyotrophic lateral sclerosis.",10.1016/j.neuron.2017.07.029,https://doi.org/10.1016/j.neuron.2017.07.029
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant GLE1 to nuclear export of mRNA,N01153,ALS Genes in the Genomic Era and their Implications for FTD.,10.1016/j.neuron.2017.07.029,https://doi.org/10.1016/j.neuron.2017.07.029
hsa05014,Amyotrophic lateral sclerosis,Mutation-caused aberrant GLE1 to nuclear export of mRNA,N01153,Amyotrophic lateral sclerosis: recent genetic highlights.,10.1016/j.neuron.2017.07.029,https://doi.org/10.1016/j.neuron.2017.07.029
hsa05016,Huntington disease,Mutation-caused aberrant Htt to mGluR5-Ca2+ -apoptotic pathway,N00985,Deranged neuronal calcium signaling and Huntington disease.,10.1016/j.bbrc.2004.08.035,https://doi.org/10.1016/j.bbrc.2004.08.035
hsa05016,Huntington disease,Mutation-caused aberrant Htt to mGluR5-Ca2+ -apoptotic pathway,N00985,Disturbed Ca2+ signaling and apoptosis of medium spiny neurons in Huntington's disease.,10.1016/j.bbrc.2004.08.035,https://doi.org/10.1016/j.bbrc.2004.08.035
hsa05016,Huntington disease,Mutation-caused aberrant Htt to mGluR5-Ca2+ -apoptotic pathway,N00985,Cause or compensation?-Altered neuronal Ca(2+) handling in Huntington's disease.,10.1016/j.bbrc.2004.08.035,https://doi.org/10.1016/j.bbrc.2004.08.035
hsa05016,Huntington disease,Mutation-caused aberrant Htt to mGluR5-Ca2+ -apoptotic pathway,N00985,The Interplay between Ca(2+) Signaling Pathways and Neurodegeneration.,10.1016/j.bbrc.2004.08.035,https://doi.org/10.1016/j.bbrc.2004.08.035
hsa05016,Huntington disease,Mutation-caused aberrant Htt to VGCC-Ca2+ -apoptotic pathway,N00986,Crosstalk between huntingtin and syntaxin 1A regulates N-type calcium channels.,10.1016/j.mcn.2005.07.016,https://doi.org/10.1016/j.mcn.2005.07.016
hsa05016,Huntington disease,Mutation-caused aberrant Htt to transport of calcium,N00987,Deranged neuronal calcium signaling and Huntington disease.,10.1016/j.bbrc.2004.08.035,https://doi.org/10.1016/j.bbrc.2004.08.035
hsa05016,Huntington disease,Mutation-caused aberrant Htt to transport of calcium,N00987,Polyglutamine-expanded huntingtin promotes sensitization of N-methyl-D-aspartate receptors via post-synaptic density 95.,10.1016/j.bbrc.2004.08.035,https://doi.org/10.1016/j.bbrc.2004.08.035
hsa05016,Huntington disease,Mutation-caused aberrant Htt to 26S proteasome-mediated protein degradation,N01061,Polyglutamine pathogenesis: emergence of unifying mechanisms for Huntington's disease and related disorders.,10.1016/S0896-6273(02)00872-3,https://doi.org/10.1016/S0896-6273(02)00872-3
hsa05016,Huntington disease,Mutation-caused aberrant Htt to 26S proteasome-mediated protein degradation,N01061,A common mechanism of proteasome impairment by neurodegenerative disease-associated oligomers.,10.1016/S0896-6273(02)00872-3,https://doi.org/10.1016/S0896-6273(02)00872-3
hsa05016,Huntington disease,Mutation-caused aberrant Htt to 26S proteasome-mediated protein degradation,N01061,Could a Common Mechanism of Protein Degradation Impairment Underlie Many Neurodegenerative Diseases?,10.1016/S0896-6273(02)00872-3,https://doi.org/10.1016/S0896-6273(02)00872-3
hsa05016,Huntington disease,Mutation-caused aberrant Htt to autophagy-vesicle nucleation,N00993,Targeting autophagy in neurodegenerative diseases.,10.1016/j.tips.2014.09.002,https://doi.org/10.1016/j.tips.2014.09.002
hsa05016,Huntington disease,Mutation-caused aberrant Htt to autophagy-vesicle nucleation,N00993,Regulation of intracellular accumulation of mutant Huntingtin by Beclin 1.,10.1016/j.tips.2014.09.002,https://doi.org/10.1016/j.tips.2014.09.002
hsa05016,Huntington disease,Mutation-caused aberrant Htt to extrinsic apoptotic pathway,N00983,Accomplices to neuronal death.,10.1038/415377a,https://doi.org/10.1038/415377a
hsa05016,Huntington disease,Mutation-caused aberrant Htt to extrinsic apoptotic pathway,N00983,Recruitment and activation of caspase-8 by the Huntingtin-interacting protein Hip-1 and a novel partner Hippi.,10.1038/415377a,https://doi.org/10.1038/415377a
hsa05016,Huntington disease,Mutation-caused aberrant Htt to TNF-JNK signaling pathway,N00992,Huntington's disease: from huntingtin function and dysfunction to therapeutic strategies.,10.1007/s00018-006-6242-0,https://doi.org/10.1007/s00018-006-6242-0
hsa05016,Huntington disease,Mutation-caused aberrant Htt to TNF-JNK signaling pathway,N00992,Kinase signalling in Huntington's disease.,10.1007/s00018-006-6242-0,https://doi.org/10.1007/s00018-006-6242-0
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex II,N00989,Mutant huntingtin and mitochondrial dysfunction.,10.1016/j.tins.2008.09.004,https://doi.org/10.1016/j.tins.2008.09.004
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex II,N00989,Mitochondrial defect in Huntington's disease caudate nucleus.,10.1016/j.tins.2008.09.004,https://doi.org/10.1016/j.tins.2008.09.004
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex II,N00989,Huntington's disease: underlying molecular mechanisms and emerging concepts.,10.1016/j.tins.2008.09.004,https://doi.org/10.1016/j.tins.2008.09.004
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex II,N00989,Energy deficit in Huntington disease: why it matters.,10.1016/j.tins.2008.09.004,https://doi.org/10.1016/j.tins.2008.09.004
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex III,N00991,Mitochondrial defect in Huntington's disease caudate nucleus.,10.1002/ana.410390317,https://doi.org/10.1002/ana.410390317
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex III,N00991,Huntington's disease: underlying molecular mechanisms and emerging concepts.,10.1002/ana.410390317,https://doi.org/10.1002/ana.410390317
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex III,N00991,A mitochondrial basis for Huntington's disease: therapeutic prospects.,10.1002/ana.410390317,https://doi.org/10.1002/ana.410390317
hsa05016,Huntington disease,Mutation-caused aberrant Htt to electron transfer in Complex III,N00991,Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.,10.1002/ana.410390317,https://doi.org/10.1002/ana.410390317
hsa05016,Huntington disease,Mutation-caused aberrant Htt to retrograde axonal transport,N00977,Huntingtin controls neurotrophic support and survival of neurons by enhancing BDNF vesicular transport along microtubules.,10.1016/j.cell.2004.06.018,https://doi.org/10.1016/j.cell.2004.06.018
hsa05016,Huntington disease,Mutation-caused aberrant Htt to retrograde axonal transport,N00977,Huntington's disease: new paths to pathogenesis.,10.1016/j.cell.2004.06.018,https://doi.org/10.1016/j.cell.2004.06.018
hsa05016,Huntington disease,Mutation-caused aberrant Htt to retrograde axonal transport,N00977,Axonal transport deficits and neurodegenerative diseases.,10.1016/j.cell.2004.06.018,https://doi.org/10.1016/j.cell.2004.06.018
hsa05016,Huntington disease,Mutation-caused aberrant Htt to anterograde axonal transport,N00979,Axonal transport deficits and neurodegenerative diseases.,10.1038/nrn3380,https://doi.org/10.1038/nrn3380
hsa05016,Huntington disease,Mutation-caused aberrant Htt to anterograde axonal transport,N00979,Nuclear and cytosolic JNK signalling in neurons.,10.1038/nrn3380,https://doi.org/10.1038/nrn3380
hsa05016,Huntington disease,Mutation-caused aberrant Htt to anterograde axonal transport,N00979,Pathogenic huntingtin inhibits fast axonal transport by activating JNK3 and phosphorylating kinesin.,10.1038/nrn3380,https://doi.org/10.1038/nrn3380
hsa05016,Huntington disease,Mutation-caused aberrant Htt to anterograde axonal transport,N00979,The genetics of axonal transport and axonal transport disorders.,10.1038/nrn3380,https://doi.org/10.1038/nrn3380
hsa05016,Huntington disease,Mutation-caused aberrant Htt to REST-mediated transcriptional repression,N00980,Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series.,10.1038/sj.embor.7400250,https://doi.org/10.1038/sj.embor.7400250
hsa05016,Huntington disease,Mutation-caused aberrant Htt to REST-mediated transcriptional repression,N00980,Normal huntingtin function: an alternative approach to Huntington's disease.,10.1038/sj.embor.7400250,https://doi.org/10.1038/sj.embor.7400250
hsa05016,Huntington disease,Mutation-caused aberrant Htt to REST-mediated transcriptional repression,N00980,Multiple Aspects of Gene Dysregulation in Huntington's Disease.,10.1038/sj.embor.7400250,https://doi.org/10.1038/sj.embor.7400250
hsa05016,Huntington disease,Mutation-caused aberrant Htt to CREB-mediated transcription,N00981,Mutant huntingtin and mitochondrial dysfunction.,10.1016/j.tins.2008.09.004,https://doi.org/10.1016/j.tins.2008.09.004
hsa05016,Huntington disease,Mutation-caused aberrant Htt to CREB-mediated transcription,N00981,"PGC-1alpha, a new therapeutic target in Huntington's disease?",10.1016/j.tins.2008.09.004,https://doi.org/10.1016/j.tins.2008.09.004
hsa05016,Huntington disease,Mutation-caused aberrant Htt to CREB-mediated transcription,N00981,Impaired Redox Signaling in Huntington's Disease: Therapeutic Implications.,10.1016/j.tins.2008.09.004,https://doi.org/10.1016/j.tins.2008.09.004
hsa05016,Huntington disease,Mutation-caused aberrant Htt to CREB-mediated transcription,N00981,"Mitochondrial Dysfunction in Huntington's Disease; Interplay Between HSF1, p53 and PGC-1alpha Transcription Factors.",10.1016/j.tins.2008.09.004,https://doi.org/10.1016/j.tins.2008.09.004
hsa05016,Huntington disease,Mutation-caused aberrant Htt to p53-mediated transcription,N00982,p53 mediates cellular dysfunction and behavioral abnormalities in Huntington's disease.,10.1016/j.neuron.2005.06.005,https://doi.org/10.1016/j.neuron.2005.06.005
hsa05016,Huntington disease,Mutation-caused aberrant Htt to p53-mediated transcription,N00982,The power of the dark side: Huntington's disease protein and p53 form a deadly alliance.,10.1016/j.neuron.2005.06.005,https://doi.org/10.1016/j.neuron.2005.06.005
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant SPTBN2 to mGluR1-TRPC3 signaling pathway,N00960,Keeping Our Calcium in Balance to Maintain Our Balance.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant SPTBN2 to mGluR1-TRPC3 signaling pathway,N00960,Mutant beta-III spectrin causes mGluR1alpha mislocalization and functional deficits in a mouse model of spinocerebellar ataxia type 5.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant SPTBN2 to mGluR1-TRPC3 signaling pathway,N00960,Spectrin mutations cause spinocerebellar ataxia type 5.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant SPTBN2 to mGluR1-TRPC3 signaling pathway,N00960,Ca(2+) signaling and spinocerebellar ataxia.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-activated GRM1 to mGluR1-TRPC3 signaling pathway,N00954,Ca(2+) signaling and spinocerebellar ataxia.,10.1016/j.bbamcr.2018.05.009,https://doi.org/10.1016/j.bbamcr.2018.05.009
hsa05017,Spinocerebellar ataxia,Mutation-activated GRM1 to mGluR1-TRPC3 signaling pathway,N00954,Dominant Mutations in GRM1 Cause Spinocerebellar Ataxia Type 44.,10.1016/j.bbamcr.2018.05.009,https://doi.org/10.1016/j.bbamcr.2018.05.009
hsa05017,Spinocerebellar ataxia,Mutation-activated ITPR1 to mGluR1-TRPC3 signaling pathway,N00958,Keeping Our Calcium in Balance to Maintain Our Balance.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-activated ITPR1 to mGluR1-TRPC3 signaling pathway,N00958,"Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.",10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-activated ITPR1 to mGluR1-TRPC3 signaling pathway,N00958,A novel gain-of-function mutation in the ITPR1 suppressor domain causes spinocerebellar ataxia with altered Ca(2+) signal patterns.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,ITPR1-reduced expression to mGluR1-TRPC3 signaling pathway,N00959,Keeping Our Calcium in Balance to Maintain Our Balance.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,ITPR1-reduced expression to mGluR1-TRPC3 signaling pathway,N00959,"Roles of inositol 1,4,5-trisphosphate receptors in spinocerebellar ataxias.",10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,ITPR1-reduced expression to mGluR1-TRPC3 signaling pathway,N00959,Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,ITPR1-reduced expression to mGluR1-TRPC3 signaling pathway,N00959,Determining the Roles of Inositol Trisphosphate Receptors in Neurodegeneration: Interdisciplinary Perspectives on a Complex Topic.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-inactivated PRKCG to mGluR1-TRPC3 signaling pathway,N00955,Ca(2+) signaling and spinocerebellar ataxia.,10.1016/j.bbamcr.2018.05.009,https://doi.org/10.1016/j.bbamcr.2018.05.009
hsa05017,Spinocerebellar ataxia,Mutation-inactivated PRKCG to mGluR1-TRPC3 signaling pathway,N00955,Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.,10.1016/j.bbamcr.2018.05.009,https://doi.org/10.1016/j.bbamcr.2018.05.009
hsa05017,Spinocerebellar ataxia,Mutation-inactivated PRKCG to mGluR1-TRPC3 signaling pathway,N00955,Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.,10.1016/j.bbamcr.2018.05.009,https://doi.org/10.1016/j.bbamcr.2018.05.009
hsa05017,Spinocerebellar ataxia,Mutation-activated PRKCG to mGluR1-TRPC3 signaling pathway,N00956,Enzymological analysis of mutant protein kinase Cgamma causing spinocerebellar ataxia type 14 and dysfunction in Ca2+ homeostasis.,10.1074/jbc.M801492200,https://doi.org/10.1074/jbc.M801492200
hsa05017,Spinocerebellar ataxia,Mutation-activated PRKCG to mGluR1-TRPC3 signaling pathway,N00956,"Neurodegeneration in SCA14 is associated with increased PKCgamma kinase activity, mislocalization and aggregation.",10.1074/jbc.M801492200,https://doi.org/10.1074/jbc.M801492200
hsa05017,Spinocerebellar ataxia,Mutation-activated PRKCG to mGluR1-TRPC3 signaling pathway,N00956,The clinical and genetic spectrum of spinocerebellar ataxia 14.,10.1074/jbc.M801492200,https://doi.org/10.1074/jbc.M801492200
hsa05017,Spinocerebellar ataxia,Mutation-activated PRKCG to mGluR1-TRPC3 signaling pathway,N00956,New mutations in protein kinase Cgamma associated with spinocerebellar ataxia type 14.,10.1074/jbc.M801492200,https://doi.org/10.1074/jbc.M801492200
hsa05017,Spinocerebellar ataxia,Mutation-activated TRPC3 to mGluR1-TRPC3 signaling pathway,N00961,Ca(2+) signaling and spinocerebellar ataxia.,10.1016/j.bbamcr.2018.05.009,https://doi.org/10.1016/j.bbamcr.2018.05.009
hsa05017,Spinocerebellar ataxia,Mutation-activated TRPC3 to mGluR1-TRPC3 signaling pathway,N00961,Keeping Our Calcium in Balance to Maintain Our Balance.,10.1016/j.bbamcr.2018.05.009,https://doi.org/10.1016/j.bbamcr.2018.05.009
hsa05017,Spinocerebellar ataxia,Mutation-activated TRPC3 to mGluR1-TRPC3 signaling pathway,N00961,A point mutation in TRPC3 causes abnormal Purkinje cell development and cerebellar ataxia in moonwalker mice.,10.1016/j.bbamcr.2018.05.009,https://doi.org/10.1016/j.bbamcr.2018.05.009
hsa05017,Spinocerebellar ataxia,Mutation-caused abberant ATXN2/3 to mGluR5-Ca2+ -apoptotic pathway,N00957,Keeping Our Calcium in Balance to Maintain Our Balance.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-caused abberant ATXN2/3 to mGluR5-Ca2+ -apoptotic pathway,N00957,"Calcium Signaling, PKC Gamma, IP3R1 and CAR8 Link Spinocerebellar Ataxias and Purkinje Cell Dendritic Development.",10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-caused abberant ATXN2/3 to mGluR5-Ca2+ -apoptotic pathway,N00957,Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-caused abberant ATXN2/3 to mGluR5-Ca2+ -apoptotic pathway,N00957,Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-caused abberant ATXN2/3 to mGluR5-Ca2+ -apoptotic pathway,N00957,Disrupted Calcium Signaling in Animal Models of Human Spinocerebellar Ataxia (SCA).,10.1016/j.bbrc.2016.07.020,https://doi.org/10.1016/j.bbrc.2016.07.020
hsa05017,Spinocerebellar ataxia,Mutation-activated CACNA1A to VGCC-Ca2+ -apoptotic pathway,N00968,Emerging pathogenic pathways in the spinocerebellar ataxias.,10.1016/j.gde.2009.02.009,https://doi.org/10.1016/j.gde.2009.02.009
hsa05017,Spinocerebellar ataxia,Mutation-activated CACNA1A to VGCC-Ca2+ -apoptotic pathway,N00968,The polyglutamine expansion in spinocerebellar ataxia type 6 causes a beta subunit-specific enhanced activation of P/Q-type calcium channels in Xenopus oocytes.,10.1016/j.gde.2009.02.009,https://doi.org/10.1016/j.gde.2009.02.009
hsa05017,Spinocerebellar ataxia,Mutation-inactivated CACNA1A to VGCC-Ca2- -apoptotic pathway,N00969,Spinocerebellar ataxia type 2: polyQ repeat variation in the CACNA1A calcium channel modifies age of onset.,10.1093/brain/awh586,https://doi.org/10.1093/brain/awh586
hsa05017,Spinocerebellar ataxia,Mutation-inactivated CACNA1A to VGCC-Ca2- -apoptotic pathway,N00969,Polyglutamine aggregates in SCA6 Purkinje cells: a tail of two toxicities.,10.1093/brain/awh586,https://doi.org/10.1093/brain/awh586
hsa05017,Spinocerebellar ataxia,Mutation-inactivated CACNA1A to VGCC-Ca2- -apoptotic pathway,N00969,Molecular pathogenesis of spinocerebellar ataxias.,10.1093/brain/awh586,https://doi.org/10.1093/brain/awh586
hsa05017,Spinocerebellar ataxia,Mutation-inactivated CACNA1A to VGCC-Ca2- -apoptotic pathway,N00969,Polyglutamine repeats of spinocerebellar ataxia 6 impair the cell-death-preventing effect of CaV2.1 Ca2+ channel--loss-of-function cellular model of SCA6.,10.1093/brain/awh586,https://doi.org/10.1093/brain/awh586
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant PDYN to transport of calcium,N00971,Elevated mutant dynorphin A causes Purkinje cell loss and motor dysfunction in spinocerebellar ataxia type 23.,10.1093/brain/awv195,https://doi.org/10.1093/brain/awv195
hsa05017,Spinocerebellar ataxia,Mutation-inactivated KCNC3 to transport of potassium,N00973,Kv3.3 channels harbouring a mutation of spinocerebellar ataxia type 13 alter excitability and induce cell death in cultured cerebellar Purkinje cells.,10.1113/jphysiol.2013.264309,https://doi.org/10.1113/jphysiol.2013.264309
hsa05017,Spinocerebellar ataxia,Mutation-inactivated KCNC3 to transport of potassium,N00973,Precision medicine in spinocerebellar ataxias: treatment based on common mechanisms of disease.,10.1113/jphysiol.2013.264309,https://doi.org/10.1113/jphysiol.2013.264309
hsa05017,Spinocerebellar ataxia,Mutation-inactivated KCND3 to transport of potassium,N00975,Novel SCA19/22-associated KCND3 mutations disrupt human KV 4.3 protein biosynthesis and channel gating.,10.1002/humu.23865,https://doi.org/10.1002/humu.23865
hsa05017,Spinocerebellar ataxia,Mutation-inactivated KCND3 to transport of potassium,N00975,Spinocerebellar ataxia type 19/22 mutations alter heterocomplex Kv4.3 channel function and gating in a dominant manner.,10.1002/humu.23865,https://doi.org/10.1002/humu.23865
hsa05017,Spinocerebellar ataxia,Mutation-inactivated ATXN3 to autophagy-vesicle nucleation,N00962,Polyglutamine tracts regulate autophagy.,10.1080/15548627.2017.1336278,https://doi.org/10.1080/15548627.2017.1336278
hsa05017,Spinocerebellar ataxia,Mutation-inactivated ATXN3 to autophagy-vesicle nucleation,N00962,Ubiquitin-mediated regulation of autophagy.,10.1080/15548627.2017.1336278,https://doi.org/10.1080/15548627.2017.1336278
hsa05017,Spinocerebellar ataxia,DAB1-overexpression to RELN-VLDLR-PI3K signaling pathway,N00964,"Clinical, genetic and neuropathological characterization of spinocerebellar ataxia type 37.",10.1093/brain/awy137,https://doi.org/10.1093/brain/awy137
hsa05017,Spinocerebellar ataxia,DAB1-overexpression to RELN-VLDLR-PI3K signaling pathway,N00964,Spinocerebellar Ataxia Type 37,10.1093/brain/awy137,https://doi.org/10.1093/brain/awy137
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant ATXN1 to RORA-mediated transcription,N00966,RORalpha-mediated Purkinje cell development determines disease severity in adult SCA1 mice.,10.1016/j.cell.2006.09.036,https://doi.org/10.1016/j.cell.2006.09.036
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant ATXN1 to RORA-mediated transcription,N00966,Deranged calcium signaling in Purkinje cells and pathogenesis in spinocerebellar ataxia 2 (SCA2) and other ataxias.,10.1016/j.cell.2006.09.036,https://doi.org/10.1016/j.cell.2006.09.036
hsa05017,Spinocerebellar ataxia,Mutation-caused aberrant ATXN1 to RORA-mediated transcription,N00966,Ca(2+) signaling and spinocerebellar ataxia.,10.1016/j.cell.2006.09.036,https://doi.org/10.1016/j.cell.2006.09.036
hsa05020,Prion disease,Scrapie conformation PrPSc to mGluR5-Ca2+ -apoptotic pathway,N01199,The release of calcium from the endoplasmic reticulum induced by amyloid-beta and prion peptides activates the mitochondrial apoptotic pathway.,10.1016/j.nbd.2008.02.003,https://doi.org/10.1016/j.nbd.2008.02.003
hsa05020,Prion disease,Scrapie conformation PrPSc to mGluR5-Ca2+ -apoptotic pathway,N01199,An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity.,10.1016/j.nbd.2008.02.003,https://doi.org/10.1016/j.nbd.2008.02.003
hsa05020,Prion disease,Scrapie conformation PrPSc to mGluR5-Ca2+ -apoptotic pathway,N01199,Abnormal calcium homeostasis and protein folding stress at the ER: A common factor in familial and infectious prion disorders.,10.1016/j.nbd.2008.02.003,https://doi.org/10.1016/j.nbd.2008.02.003
hsa05020,Prion disease,Scrapie conformation PrPSc to mGluR5-Ca2+ -apoptotic pathway,N01199,Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases.,10.1016/j.nbd.2008.02.003,https://doi.org/10.1016/j.nbd.2008.02.003
hsa05020,Prion disease,Scrapie conformation PrPSc to VGCC-Ca2+ -apoptotic pathway,N01201,The Interplay between Ca(2+) Signaling Pathways and Neurodegeneration.,10.3390/ijms20236004,https://doi.org/10.3390/ijms20236004
hsa05020,Prion disease,Scrapie conformation PrPSc to VGCC-Ca2+ -apoptotic pathway,N01201,Apoptotic cell death and impairment of L-type voltage-sensitive calcium channel activity in rat cerebellar granule cells treated with the prion protein fragment??106-126.,10.3390/ijms20236004,https://doi.org/10.3390/ijms20236004
hsa05020,Prion disease,Scrapie conformation PrPSc to VGCC-Ca2+ -apoptotic pathway,N01201,Scrapie-infected GT1-1 cells show impaired function of voltage-gated N-type calcium channels (Ca(v) 2.2) which is ameliorated by quinacrine treatment.,10.3390/ijms20236004,https://doi.org/10.3390/ijms20236004
hsa05020,Prion disease,Scrapie conformation PrPSc to transport of calcium,N01200,Prions Strongly Reduce NMDA Receptor S-Nitrosylation Levels at Pre-symptomatic and Terminal Stages of Prion Diseases.,10.1007/s12035-019-1505-6,https://doi.org/10.1007/s12035-019-1505-6
hsa05020,Prion disease,Scrapie conformation PrPSc to transport of calcium,N01200,Copper-dependent regulation of NMDA receptors by cellular prion protein: implications for neurodegenerative disorders.,10.1007/s12035-019-1505-6,https://doi.org/10.1007/s12035-019-1505-6
hsa05020,Prion disease,Scrapie conformation PrPSc to transport of calcium,N01200,"Almost a century of prion protein(s): From pathology to physiology, and back to pathology.",10.1007/s12035-019-1505-6,https://doi.org/10.1007/s12035-019-1505-6
hsa05020,Prion disease,Scrapie conformation PrPSc to 26S proteasome-mediated protein degradation,N01197,Disease-associated prion protein oligomers inhibit the 26S proteasome.,10.1016/j.molcel.2007.04.001,https://doi.org/10.1016/j.molcel.2007.04.001
hsa05020,Prion disease,Scrapie conformation PrPSc to 26S proteasome-mediated protein degradation,N01197,Misfolded PrP and a novel mechanism of proteasome inhibition.,10.1016/j.molcel.2007.04.001,https://doi.org/10.1016/j.molcel.2007.04.001
hsa05020,Prion disease,Scrapie conformation PrPSc to 26S proteasome-mediated protein degradation,N01197,Misfolded PrP impairs the UPS by interaction with the 20S proteasome and inhibition of substrate entry.,10.1016/j.molcel.2007.04.001,https://doi.org/10.1016/j.molcel.2007.04.001
hsa05020,Prion disease,Scrapie conformation PrPSc to 26S proteasome-mediated protein degradation,N01197,Regulation of proteasomes in prion disease.,10.1016/j.molcel.2007.04.001,https://doi.org/10.1016/j.molcel.2007.04.001
hsa05020,Prion disease,Scrapie conformation PrPSc to PERK-ATF4 signaling pathway,N01198,The unfolded protein response in neurodegenerative disorders - therapeutic modulation of the PERK pathway.,10.1111/febs.14422,https://doi.org/10.1111/febs.14422
hsa05020,Prion disease,Scrapie conformation PrPSc to PERK-ATF4 signaling pathway,N01198,Fine-tuning PERK signaling for neuroprotection.,10.1111/febs.14422,https://doi.org/10.1111/febs.14422
hsa05020,Prion disease,Scrapie conformation PrPSc to PERK-ATF4 signaling pathway,N01198,What Is Our Current Understanding of PrP(Sc)-Associated Neurotoxicity and Its Molecular Underpinnings?,10.1111/febs.14422,https://doi.org/10.1111/febs.14422
hsa05020,Prion disease,Scrapie conformation PrPSc to PERK-ATF4 signaling pathway,N01198,The stress of prion disease.,10.1111/febs.14422,https://doi.org/10.1111/febs.14422
hsa05020,Prion disease,Scrapie conformation PrPSc to PERK-ATF4 signaling pathway,N01198,Molecular mechanisms of neurodegeneration mediated by dysfunctional subcellular organelles in transmissible spongiform encephalopathies.,10.1111/febs.14422,https://doi.org/10.1111/febs.14422
hsa05020,Prion disease,Scrapie conformation PrPSc to PRNP-PI3K-NOX2 signaling pathway,N01205,Understanding the neurospecificity of Prion protein signaling.,10.2741/3682,https://doi.org/10.2741/3682
hsa05020,Prion disease,Scrapie conformation PrPSc to PRNP-PI3K-NOX2 signaling pathway,N01205,PrP(C) signalling in neurons: from basics to clinical challenges.,10.2741/3682,https://doi.org/10.2741/3682
hsa05020,Prion disease,Scrapie conformation PrPSc to PRNP-PI3K-NOX2 signaling pathway,N01205,Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment.,10.2741/3682,https://doi.org/10.2741/3682
hsa05020,Prion disease,Scrapie conformation PrPSc to PRNP-PI3K-NOX2 signaling pathway,N01205,Prion protein and its role in signal transduction.,10.2741/3682,https://doi.org/10.2741/3682
hsa05020,Prion disease,Oligomeric conformation PrPc to anterograde axonal transport,N01202,"Protein Misfolding, Signaling Abnormalities and Altered Fast Axonal Transport: Implications for Alzheimer and Prion Diseases.",10.3389/fncel.2019.00350,https://doi.org/10.3389/fncel.2019.00350
hsa05020,Prion disease,Oligomeric conformation PrPc to anterograde axonal transport,N01202,Prion protein inhibits fast axonal transport through a mechanism involving casein kinase 2.,10.3389/fncel.2019.00350,https://doi.org/10.3389/fncel.2019.00350
hsa05020,Prion disease,Scrapie conformation PrPSc to Notch singling pathway,N01203,Notch-1 activation and dendritic atrophy in prion disease.,10.1073/pnas.0408612101,https://doi.org/10.1073/pnas.0408612101
hsa05020,Prion disease,Scrapie conformation PrPSc to Notch singling pathway,N01203,PrPSc accumulation in neuronal plasma membranes links Notch-1 activation to dendritic degeneration in prion diseases.,10.1073/pnas.0408612101,https://doi.org/10.1073/pnas.0408612101
hsa04730,Long-term depression,mGluR1-TRPC3 signaling pathway,N00953,Type-1 metabotropic glutamate receptor signaling in cerebellar Purkinje cells in health and disease.,10.12688/f1000research.10485.1,https://doi.org/10.12688/f1000research.10485.1
hsa04730,Long-term depression,mGluR1-TRPC3 signaling pathway,N00953,"The Moonwalker mouse: new insights into TRPC3 function, cerebellar development, and ataxia.",10.12688/f1000research.10485.1,https://doi.org/10.12688/f1000research.10485.1
hsa04730,Long-term depression,mGluR1-TRPC3 signaling pathway,N00953,Regulation of canonical transient receptor potential (TRPC) channel function by diacylglycerol and protein kinase C.,10.12688/f1000research.10485.1,https://doi.org/10.12688/f1000research.10485.1
hsa04730,Long-term depression,mGluR1-TRPC3 signaling pathway,N00953,Negative regulation of TRPC3 channels by protein kinase C-mediated phosphorylation of serine 712.,10.12688/f1000research.10485.1,https://doi.org/10.12688/f1000research.10485.1
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,The versatility and universality of calcium signalling.,10.1038/35036035,https://doi.org/10.1038/35036035
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,Role of GPCR signaling and calcium dysregulation in Alzheimer's disease.,10.1038/35036035,https://doi.org/10.1038/35036035
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,The MCU complex in cell death.,10.1038/35036035,https://doi.org/10.1038/35036035
hsa04720,Long-term potentiation,mGluR5-Ca2+ -apoptotic pathway,N00984,Calcium Dynamics as a Machine for Decoding Signals.,10.1038/35036035,https://doi.org/10.1038/35036035
hsa04020,Calcium signaling pathway,mAChR-Ca2+ -apoptotic pathway,N01000,The versatility and universality of calcium signalling.,10.1038/35036035,https://doi.org/10.1038/35036035
hsa04020,Calcium signaling pathway,mAChR-Ca2+ -apoptotic pathway,N01000,Role of GPCR signaling and calcium dysregulation in Alzheimer's disease.,10.1038/35036035,https://doi.org/10.1038/35036035
hsa04020,Calcium signaling pathway,mAChR-Ca2+ -apoptotic pathway,N01000,The MCU complex in cell death.,10.1038/35036035,https://doi.org/10.1038/35036035
hsa04020,Calcium signaling pathway,mAChR-Ca2+ -apoptotic pathway,N01000,Calcium Dynamics as a Machine for Decoding Signals.,10.1038/35036035,https://doi.org/10.1038/35036035
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,Voltage-gated calcium channels.,10.1101/cshperspect.a003947,https://doi.org/10.1101/cshperspect.a003947
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,Structure and Pharmacology of Voltage-Gated Sodium and Calcium Channels.,10.1101/cshperspect.a003947,https://doi.org/10.1101/cshperspect.a003947
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,Ion channels in the regulation of apoptosis.,10.1101/cshperspect.a003947,https://doi.org/10.1101/cshperspect.a003947
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,Calcium Dynamics as a Machine for Decoding Signals.,10.1101/cshperspect.a003947,https://doi.org/10.1101/cshperspect.a003947
hsa04724,Glutamatergic synapse,VGCC-Ca2+ -apoptotic pathway,N00967,ER Stress-Mediated Signaling: Action Potential and Ca(2+) as Key Players.,10.1101/cshperspect.a003947,https://doi.org/10.1101/cshperspect.a003947
hsa04724,Glutamatergic synapse,Transport of calcium,N00970,Postsynaptic signaling and plasticity mechanisms.,10.1126/science.1075333,https://doi.org/10.1126/science.1075333
hsa04724,Glutamatergic synapse,Transport of calcium,N00970,Activation Mechanisms of the NMDA Receptor,10.1126/science.1075333,https://doi.org/10.1126/science.1075333
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01019,Twenty years since the discovery of the parkin gene.,10.1007/s00702-017-1742-7,https://doi.org/10.1007/s00702-017-1742-7
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01019,Part I: parkin-associated proteins and Parkinson's disease.,10.1007/s00702-017-1742-7,https://doi.org/10.1007/s00702-017-1742-7
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01021,Twenty years since the discovery of the parkin gene.,10.1007/s00702-017-1742-7,https://doi.org/10.1007/s00702-017-1742-7
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01021,Part I: parkin-associated proteins and Parkinson's disease.,10.1007/s00702-017-1742-7,https://doi.org/10.1007/s00702-017-1742-7
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01021,"An unfolded putative transmembrane polypeptide, which can lead to endoplasmic reticulum stress, is a substrate of Parkin.",10.1007/s00702-017-1742-7,https://doi.org/10.1007/s00702-017-1742-7
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01021,Endoplasmic reticulum stress and Parkinson's disease: the role of HRD1 in averting apoptosis in neurodegenerative disease.,10.1007/s00702-017-1742-7,https://doi.org/10.1007/s00702-017-1742-7
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01023,Twenty years since the discovery of the parkin gene.,10.1007/s00702-017-1742-7,https://doi.org/10.1007/s00702-017-1742-7
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01023,Part I: parkin-associated proteins and Parkinson's disease.,10.1007/s00702-017-1742-7,https://doi.org/10.1007/s00702-017-1742-7
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01025,Twenty years since the discovery of the parkin gene.,10.1007/s00702-017-1742-7,https://doi.org/10.1007/s00702-017-1742-7
hsa04120,Ubiquitin mediated proteolysis,Parkin-mediated ubiquitination,N01025,Part I: parkin-associated proteins and Parkinson's disease.,10.1007/s00702-017-1742-7,https://doi.org/10.1007/s00702-017-1742-7
hsa03050,Proteasome,26S proteasome-mediated protein degradation,N01029,Dynamic Regulation of the 26S Proteasome: From Synthesis to Degradation.,10.3389/fmolb.2019.00040,https://doi.org/10.3389/fmolb.2019.00040
hsa03050,Proteasome,26S proteasome-mediated protein degradation,N01029,The proteasome: a novel target for cancer chemotherapy.,10.3389/fmolb.2019.00040,https://doi.org/10.3389/fmolb.2019.00040
hsa03050,Proteasome,26S proteasome-mediated protein degradation,N01029,Ubiquitin C-terminal hydrolase l1 in tumorigenesis.,10.3389/fmolb.2019.00040,https://doi.org/10.3389/fmolb.2019.00040
hsa05012,Parkinson disease,UCHL1-mediated hydrolysis,N01027,Ubiquitin C-terminal hydrolase l1 in tumorigenesis.,10.1155/2012/123706,https://doi.org/10.1155/2012/123706
hsa04141,Protein processing in endoplasmic reticulum,PERK-ATF4 signaling pathway,N01009,The unfolded protein response: from stress pathway to homeostatic regulation.,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,PERK-ATF4 signaling pathway,N01009,Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities.,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,PERK-ATF4 signaling pathway,N01009,Endoplasmic reticulum stress in human skeletal muscle: any contribution to sarcopenia?,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,PERK-ATF4 signaling pathway,N01009,Endoplasmic reticulum stress and lipid metabolism: mechanisms and therapeutic potential.,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-XBP1 signaling pathway,N01011,The unfolded protein response: from stress pathway to homeostatic regulation.,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-XBP1 signaling pathway,N01011,Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities.,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-XBP1 signaling pathway,N01011,Endoplasmic reticulum stress in human skeletal muscle: any contribution to sarcopenia?,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-XBP1 signaling pathway,N01011,Endoplasmic reticulum stress and lipid metabolism: mechanisms and therapeutic potential.,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-JNK signaling pathway,N01013,Endoplasmic reticulum stress in human skeletal muscle: any contribution to sarcopenia?,10.3389/fphys.2013.00236,https://doi.org/10.3389/fphys.2013.00236
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-JNK signaling pathway,N01013,Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities.,10.3389/fphys.2013.00236,https://doi.org/10.3389/fphys.2013.00236
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-JNK signaling pathway,N01013,PERK-opathies: An Endoplasmic Reticulum Stress Mechanism Underlying Neurodegeneration.,10.3389/fphys.2013.00236,https://doi.org/10.3389/fphys.2013.00236
hsa04141,Protein processing in endoplasmic reticulum,IRE1a-JNK signaling pathway,N01013,IRE1alpha Implications in Endoplasmic Reticulum Stress-Mediated Development and Pathogenesis of Autoimmune Diseases.,10.3389/fphys.2013.00236,https://doi.org/10.3389/fphys.2013.00236
hsa04141,Protein processing in endoplasmic reticulum,ATF6-mediated transcription,N01015,The unfolded protein response: from stress pathway to homeostatic regulation.,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,ATF6-mediated transcription,N01015,Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities.,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,ATF6-mediated transcription,N01015,Endoplasmic reticulum stress in human skeletal muscle: any contribution to sarcopenia?,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04141,Protein processing in endoplasmic reticulum,ATF6-mediated transcription,N01015,Endoplasmic reticulum stress and lipid metabolism: mechanisms and therapeutic potential.,10.1126/science.1209038,https://doi.org/10.1126/science.1209038
hsa04140,Autophagy - animal,C9orf72-mediated autophagy initiation,N01142,C9orf72 plays a central role in Rab GTPase-dependent regulation of autophagy.,10.1080/21541248.2016.1240495,https://doi.org/10.1080/21541248.2016.1240495
hsa04140,Autophagy - animal,C9orf72-mediated autophagy initiation,N01142,The C9orf72 protein interacts with Rab1a and the ULK1 complex to regulate initiation of autophagy.,10.1080/21541248.2016.1240495,https://doi.org/10.1080/21541248.2016.1240495
hsa04140,Autophagy - animal,C9orf72-mediated autophagy initiation,N01142,A C9ORF72/SMCR8-containing complex regulates ULK1 and plays a dual role in autophagy.,10.1080/21541248.2016.1240495,https://doi.org/10.1080/21541248.2016.1240495
hsa04140,Autophagy - animal,"Autophagy-vesicle nucleation/elongation/maturation, mTORC1-PI3KC3-C1",N00155,Autophagy--a key player in cellular and body metabolism.,10.1038/nrendo.2014.35,https://doi.org/10.1038/nrendo.2014.35
hsa04140,Autophagy - animal,"Autophagy-vesicle nucleation/elongation/maturation, mTORC1-PI3KC3-C1",N00155,Autophagy regulation by nutrient signaling.,10.1038/nrendo.2014.35,https://doi.org/10.1038/nrendo.2014.35
hsa04137,Mitophagy - animal,PINK1-Parkin-mediated MFN2 degradation,N01052,"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology.",10.1038/s41556-018-0176-2,https://doi.org/10.1038/s41556-018-0176-2
hsa04137,Mitophagy - animal,PINK1-Parkin-mediated MFN2 degradation,N01052,A Molecular Approach to Mitophagy and Mitochondrial Dynamics.,10.1038/s41556-018-0176-2,https://doi.org/10.1038/s41556-018-0176-2
hsa04137,Mitophagy - animal,PINK1-Parkin-mediated MFN2 degradation,N01052,Mfn2 ubiquitination by PINK1/parkin gates the p97-dependent release of ER from mitochondria to drive mitophagy.,10.1038/s41556-018-0176-2,https://doi.org/10.1038/s41556-018-0176-2
hsa04137,Mitophagy - animal,PINK-Parkin-mediated autophagosome formation,N01137,"Mechanisms of mitophagy in cellular homeostasis, physiology and pathology.",10.1038/s41556-018-0176-2,https://doi.org/10.1038/s41556-018-0176-2
hsa04137,Mitophagy - animal,PINK-Parkin-mediated autophagosome formation,N01137,A Molecular Approach to Mitophagy and Mitochondrial Dynamics.,10.1038/s41556-018-0176-2,https://doi.org/10.1038/s41556-018-0176-2
hsa04137,Mitophagy - animal,PINK-Parkin-mediated autophagosome formation,N01137,Landscape of the PARKIN-dependent ubiquitylome in response to mitochondrial depolarization.,10.1038/s41556-018-0176-2,https://doi.org/10.1038/s41556-018-0176-2
hsa04137,Mitophagy - animal,PINK-Parkin-mediated autophagosome formation,N01137,Dynamics of PARKIN-Dependent Mitochondrial Ubiquitylation in Induced Neurons and Model Systems Revealed by Digital Snapshot Proteomics.,10.1038/s41556-018-0176-2,https://doi.org/10.1038/s41556-018-0176-2
hsa04137,Mitophagy - animal,PINK-Parkin-mediated autophagosome formation,N01137,Expanding the ubiquitin code through post-translational modification.,10.1038/s41556-018-0176-2,https://doi.org/10.1038/s41556-018-0176-2
hsa04137,Mitophagy - animal,TBK1-mediated autophagosome formation,N01140,Expanding the ubiquitin code through post-translational modification.,10.15252/embr.201540891,https://doi.org/10.15252/embr.201540891
hsa04137,Mitophagy - animal,TBK1-mediated autophagosome formation,N01140,The Function of Autophagy in Neurodegenerative Diseases.,10.15252/embr.201540891,https://doi.org/10.15252/embr.201540891
hsa04137,Mitophagy - animal,TBK1-mediated autophagosome formation,N01140,Phosphorylation of OPTN by TBK1 enhances its binding to Ub chains and promotes selective autophagy of damaged mitochondria.,10.15252/embr.201540891,https://doi.org/10.15252/embr.201540891
hsa04137,Mitophagy - animal,TBK1-mediated autophagosome formation,N01140,TBK1 controls autophagosomal engulfment of polyubiquitinated mitochondria through p62/SQSTM1 phosphorylation.,10.15252/embr.201540891,https://doi.org/10.15252/embr.201540891
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death.,10.1038/nrm3143,https://doi.org/10.1038/nrm3143
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,The role of BH3-only proteins in the immune system.,10.1038/nrm3143,https://doi.org/10.1038/nrm3143
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Mitochondria and cell death: outer membrane permeabilization and beyond.,10.1038/nrm3143,https://doi.org/10.1038/nrm3143
hsa04210,Apoptosis,Crosstalk between extrinsic and intrinsic apoptotic pathways,N00146,Apoptosis inducing lead compounds isolated from marine organisms of potential relevance in cancer treatment.,10.1038/nrm3143,https://doi.org/10.1038/nrm3143
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Ubiquitylation in apoptosis: a post-translational modification at the edge of life and death.,10.1038/nrm3143,https://doi.org/10.1038/nrm3143
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,The role of BH3-only proteins in the immune system.,10.1038/nrm3143,https://doi.org/10.1038/nrm3143
hsa04210,Apoptosis,Intrinsic apoptotic pathway,N00098,Mitochondria and cell death: outer membrane permeabilization and beyond.,10.1038/nrm3143,https://doi.org/10.1038/nrm3143
hsa05010,Alzheimer disease,AGE-RAGE signaling pathway,N00994,RAGE-mediated cell signaling.,10.1007/978-1-62703-230-8_15,https://doi.org/10.1007/978-1-62703-230-8_15
hsa05010,Alzheimer disease,AGE-RAGE signaling pathway,N00994,"AGEs, RAGE, and diabetic retinopathy.",10.1007/978-1-62703-230-8_15,https://doi.org/10.1007/978-1-62703-230-8_15
hsa05010,Alzheimer disease,AGE-RAGE signaling pathway,N00994,Role of advanced glycation end products in cellular signaling.,10.1007/978-1-62703-230-8_15,https://doi.org/10.1007/978-1-62703-230-8_15
hsa05010,Alzheimer disease,AGE-RAGE signaling pathway,N00994,Cellular signalling of the receptor for advanced glycation end products (RAGE).,10.1007/978-1-62703-230-8_15,https://doi.org/10.1007/978-1-62703-230-8_15
hsa05010,Alzheimer disease,AGE-RAGE signaling pathway,N00994,Advanced glycation end products: sparking the development of diabetic vascular injury.,10.1007/978-1-62703-230-8_15,https://doi.org/10.1007/978-1-62703-230-8_15
hsa00190,Oxidative phosphorylation,Electron transfer in Complex I,N00995,Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.,10.1111/cns.12655,https://doi.org/10.1111/cns.12655
hsa00190,Oxidative phosphorylation,Electron transfer in Complex I,N00995,Mitochondrial respiratory chain complexes: apoptosis sensors mutated in cancer?,10.1111/cns.12655,https://doi.org/10.1111/cns.12655
hsa00190,Oxidative phosphorylation,Electron transfer in Complex II,N00988,Succinate dehydrogenase: Prospect for neurodegenerative diseases.,10.1016/j.mito.2017.12.002,https://doi.org/10.1016/j.mito.2017.12.002
hsa00190,Oxidative phosphorylation,Electron transfer in Complex II,N00988,Oxidative phosphorylation at the fin de siecle.,10.1016/j.mito.2017.12.002,https://doi.org/10.1016/j.mito.2017.12.002
hsa00190,Oxidative phosphorylation,Electron transfer in Complex III,N00990,Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.,10.1111/cns.12655,https://doi.org/10.1111/cns.12655
hsa00190,Oxidative phosphorylation,Electron transfer in Complex III,N00990,Oxidative phosphorylation at the fin de siecle.,10.1111/cns.12655,https://doi.org/10.1111/cns.12655
hsa00190,Oxidative phosphorylation,Electron transfer in Complex IV,N00998,Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment.,10.1111/cns.12655,https://doi.org/10.1111/cns.12655
hsa00190,Oxidative phosphorylation,Electron transfer in Complex IV,N00998,Oxidative phosphorylation at the fin de siecle.,10.1111/cns.12655,https://doi.org/10.1111/cns.12655
hsa00190,Oxidative phosphorylation,Electron transfer in Complex IV,N00998,Mitochondrial cytochrome c oxidase deficiency.,10.1111/cns.12655,https://doi.org/10.1111/cns.12655
hsa05016,Huntington disease,Retrograde axonal transport,N00976,Regulation of Axonal Transport by Protein Kinases.,10.1016/j.tibs.2015.08.003,https://doi.org/10.1016/j.tibs.2015.08.003
hsa05016,Huntington disease,Retrograde axonal transport,N00976,Axonal transport deficits and neurodegenerative diseases.,10.1016/j.tibs.2015.08.003,https://doi.org/10.1016/j.tibs.2015.08.003
hsa05016,Huntington disease,Retrograde axonal transport,N00976,"Microtubule assembly, organization and dynamics in axons and dendrites.",10.1016/j.tibs.2015.08.003,https://doi.org/10.1016/j.tibs.2015.08.003
hsa05016,Huntington disease,Anterograde axonal transport,N00978,Regulation of Axonal Transport by Protein Kinases.,10.1016/j.tibs.2015.08.003,https://doi.org/10.1016/j.tibs.2015.08.003
hsa05016,Huntington disease,Anterograde axonal transport,N00978,Axonal transport deficits and neurodegenerative diseases.,10.1016/j.tibs.2015.08.003,https://doi.org/10.1016/j.tibs.2015.08.003
hsa05016,Huntington disease,Anterograde axonal transport,N00978,"Microtubule assembly, organization and dynamics in axons and dendrites.",10.1016/j.tibs.2015.08.003,https://doi.org/10.1016/j.tibs.2015.08.003
